Pharmed Limited Unlisted Shares
Pharmed Limited Unlisted Shares Share Price
Industry manufacturingSector pharmaDepository NSDL, CDSL
52W High
₹5,168.00
52W Low
₹682.50
1Y Return
-15.7%
Overview
About The Company
Deep Dive
Pharmed Limited Unlisted Shares Unlisted Shares
Financials · IPO timeline · Growth projects
Pharmed Limited (PL) is engaged in the manufacturing and marketing of pharmaceutical products in orthopedic, gynecologic, general health, pediatric and gastroenterology segments. It offers products of health, joint, bone and tendon health, pain management, cardio-diabetic health; ear, nose, and throat health and many more. The company sells its products under the brands 'Supracal', 'Cartigen', 'Absolut' and 'Tendocare'. The company has its branch offices located in Bangalore, Mumbai, Delhi, and Kolkata. The company was incorporated in 1946 and has its registered office located in Maharashtra.
Strong
Market Position
Consistent
YoY Growth
Experienced
Management
Fundamentals
Key Indicators
A snapshot of Pharmed Limited Unlisted Shares's financial health, valuation multiples and capital efficiency at a glance.
Current Share Price₹735.00
Face Value / Share₹2.00
Book Value / Share₹834.50
Price to Earning (PE)3.90
Price / Sales0.60
Price / Book0.90
Outstanding Shares0.43Cr
Market Cap₹316.00Cr
Debt / Equity0.25
Dividend / Share₹0.00
Dividend %0.00%
Return on Total Assets18%
Return on Equity22%
Working Capital Return26%
Pharmed Limited Unlisted SharesNSDL, CDSL Unlisted Shares
₹735.00
Estimated total₹7,350.00
Settled in T+2 days · KYC verified dealers
Performance
Pricing Trends
6-Month Movement
₹735.00↗ +0.00 (+0.00%)
Financials
Financial Performance
| Indicators | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 528.6 | 487.3 | 436.0 | 359.6 | 286.3 | 319.9 | 273.4 | 233.0 |
| Expense | 417.2 | 403.7 | 389.1 | 302.0 | 234.4 | 286.3 | 249.2 | 214.1 |
| EBITDA | 111.4 | 83.6 | 46.9 | 57.6 | 51.9 | 33.6 | 24.1 | 18.9 |
| Other Cost | 5.3 | 5.4 | 3.6 | 2.6 | 2.3 | 2.2 | 2.4 | 2.3 |
| PBT | 106.2 | 78.2 | 43.2 | 55.0 | 49.6 | 31.4 | 21.7 | 16.6 |
| Tax Expense | 25.3 | 19.8 | 10.2 | 12.7 | 12.2 | 7.4 | 6.6 | 5.4 |
| PAT | 80.8 | 58.4 | 33.0 | 42.3 | 37.4 | 24.0 | 15.1 | 11.2 |
| Other Inc./Exp. | -1.6 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | 79.3 | 58.1 | 33.0 | 42.3 | 37.4 | 24.0 | 15.1 | 11.2 |
| Shares O/S | 0.43 | 0.43 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 |
| EPS (₹) | 187.51 | 135.28 | 76.90 | 98.40 | 86.90 | 55.80 | 35.20 | 26.10 |
| Rev. Growth % | 8.5% | 11.8% | 21.2% | 25.6% | -10.5% | 17.0% | 17.3% | — |
| EBITDA Mgn % | 21.1% | 17.2% | 10.8% | 16.0% | 18.1% | 10.5% | 8.8% | 8.1% |
| Net Mgn % | 15.0% | 11.9% | 7.6% | 11.8% | 13.1% | 7.5% | 5.5% | 4.8% |
| EPS Growth | 38.6% | 75.9% | -21.8% | 13.2% | 55.7% | 58.5% | 34.9% | — |
Corporate
Registered Address
#
ISIN
INE0EEI01017
§
PAN
AAACP2191A
Address
PHARMED HOUSE141 WALCHAND, Mumbai,MH-400001
RTA
na
Leadership
Management Team
SA
Suneet Aurora
Chairman & Managing Director
VK
Venkataramani Krishnamurthy
Chief Financial Officer
Reports
Download Financial Results
📄Annual Report 2023
▼📅Select Year
▼Top Unlisted companies
Current Price: ₹ 2043.93/-
Current Price: ₹ 2756.25/-
Current Price: ₹ 535.5/-
Current Price: ₹ 443.93/-
Current Price: ₹ 8741.25/-
Current Price: ₹ 260/-
Current Price: ₹ 2599.8/-
Current Price: ₹ 2600/-
Help
Frequently Asked Questions
?
Still have questions?
Our expert team typically responds within 30 minutes during market hours.
Due to past performance and potential to grow, investment in Pharmed Ltd unlisted shares is a wise choice. At Stockify, you can easily buy and sell unlisted shares of Pharmed Ltd. You just need to connect with our expert share brokers, and they will help you throughout the process.
